Macular Degeneration Vitamins - Results of Eye Disease Study

macular degeneration and macular degeneration vitamin

Macular Degeneration Vitamin in the News

Macular Degeneration Vitamin were successful in a ground-breaking major study sponsored by the National Eye Institute, one of the Federal government’s National Institutes of Health, and conducted at 11 major medical center research facilities around the country - The Age Related Eye Disease Study (AREDS).

In that study, specific macular degeneration vitamin ingredients and amounts were found to slow the progression of macular degeneration in those patients with intermediate or advanced disease.

Macular Degeneration vitamins promote visual health

Where Are These Supplements Available?		Commonly Asked Questions

Two macular degeneration formulas from major pharmaceutical manufacturers exist which exactly duplicate the formula in the Age Related Eye Disease Study. For information regarding the manufacturers and availability of these macular degeneration vitamin, CLICK HERE.		What is AMD? Other Resources Home Page

Which Vitamin are Important?		Will taking vitamin prevent this problem?

Specific ingredients and amounts were found to slow the progression in those patients with intermediate or advanced disease. It is believed that macular degeneration vitamin contain specific anti-oxidants and Zinc that promote the continued health of the retina and tissues surrounding the retina.		In the absence of any findings, there is no research published that shows that taking vitamin can prevent this disease. However, the AREDS study did show, if there was disease in only one eye, that taking proper vitamin supplements prevented or slowed the progress of the disease in the opposite eye.

High doses of certain dietary supplements provide the first effective treatment for the leading cause of vision loss among the elderly, a new nationwide clinical study has concluded. The disease, macular degeneration, destroys the central portion of the retina, the light-gathering cells at the back of the eye. Among people who already have significant yellowish deposits accumulating at the back of their eyes — the hallmark of the disease — the supplements cut their risk of vision loss by one-fifth.

The vitamin supplements — a combination of zinc and the antioxidants vitamin C, vitamin E and beta-carotene — did not appear to slow the early stages of the disease, when the yellowish deposits develop, but that is a normal part of aging and is not necessarily of concern.

Among those whose disease had progressed to the intermediate stage, the zinc supplements reduced by 11 percent the risk of the disease progressing to the advanced stage, and the antioxidants reduced the risk by 10 percent. When the two were combined, the risk dropped by 19 percent. The study followed the participants for 6.5 years on average.